Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Paul S. who wrote (966)	9/30/1998 1:02:00 AM
From: Wisee	Read Replies (1) \| Respond to of 1185

Paul I think Bob Rieder is referring to the pro-erectile drug that is in Nortran's pipeline. Nortran's drugs have been under development for close to two years, with excellent results to date. The major that does the licensing agreement with Nortran in all likelihood will fast-track the project to ensure that it has a piece of this lucrative market. Has anybody followed ICOS Corp. (ICOS on NASDAQ). Along with other drugs in it's pipeline, it too has an impotence compound in clinical trials. It's market cap. presently is $730million US. We think someday Nortran will have a similar market cap. Good things happen to those that wait.. Wisee